Clinical trialNCT06244004RecruitingPhase 2Interventional

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

SponsorNorthwestern UniversityEnrollment125Castration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David VanderWeele, MD, PhD
Northwestern University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Northwestern University
Chicago, Illinois, United States
David VanderWeele
Recruiting
Northwestern Medicine: Kishwaukee
DeKalb, Illinois, United States
David VanderWeele, MD, PHD
Recruiting
Northwestern Medicine: Delnor
Geneva, Illinois, United States
David VanderWeele, M
Recruiting
Northwestern University Oak Brook Il453
Oak Brook, Illinois, United States
David VanderWeele, MD, PhD
Recruiting
Northwestern Medicine Orland Park
Orland Park, Illinois, United States
David VanderWeele, MD, PhD
Not, yet, recruiting
Northwestern Medicine: Warrenville
Warrenville, Illinois, United States
David VanderWeele, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Feb 2024
Primary completion: 18 Feb 2027
Completion: 18 Feb 2028
Last update posted: 30 Mar 2026
Registered enrollment: 125
Registry id: NCT06244004

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.